Investors are showing interest
Angle's new liquid biopsy test sounds like a million bucks doesn't it? Well, investors certainly seem to think so. This promising new way to detect ovarian cancer has attracted a lot of attention in the healthcare business. Angle's stock price rose 7% over one week alone. It seems that the business world also has a lot of faith in Angle's new test.